Published reports indicate that tumor-derived MTA metabolite acts to suppress T-cell functions62 and to inhibit arginine methylation of STAT1, thus leading to diminution of the biological responses to interferons (IFNs)63, which is essential for T-cell function and PD-L1 expression. The gene discussed is CD274; the disease is neoplasm.